Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Matérias relacionadas
Comentários
Deixe um comentário
Todos os campos são requeridos
Mais vistas
- Ministro das Relações Exteriores de Cuba denuncia que Israel está obstruindo a ajuda humanitária à Palestina
- Conselho de Ministros aprova o Programa do Governo para corrigir distorções e relançar a economia em 2025
- Ministro das Relações Exteriores rejeita novas medidas dos EUA contra Cuba
- Academia de Ciências de Cuba concede reconhecimento a Frei Betto
- Sheinbaum analisa progresso do Plano México
